|
2023
|
Invention
|
Antifungal dry powders.
The invention relates to dry powder formulations comprising respirable d... |
|
|
P/S
|
Pharmaceuticals used for the treatment and prevention of diseases, disorders and conditions of th... |
|
|
Invention
|
Methods of using itraconazole dry powders. The present disclosure relates to a method of treating... |
|
|
Invention
|
Monovalent metal cation dry powders for inhalation.
The present invention is directed toward res... |
|
|
Invention
|
Methods for treating cancer using inhaled angiogenesis inhibitor. The present disclosure relates ... |
|
2022
|
Invention
|
Dry powder formulations of narrow spectrum kinase inhibitors. The present disclosure relates to r... |
|
|
P/S
|
New product commercialization services, namely, commercialization of pharmaceuticals and drug del... |
|
|
Invention
|
Dihydroergotamine dry powder formulations and methods of use.
The present disclosure relates to ... |
|
|
Invention
|
Dihydroergotamine dry powder formulations and methods of use. The present disclosure relates to d... |
|
2020
|
Invention
|
Monovalent metal cation dry powders for inhalation. +), are small and dispersible. |
|
|
Invention
|
Inhalable dry powders. The invention related to dry powders that contain a therapeutic agent. The... |
|
2019
|
Invention
|
Monovalent metal cation dry powders.
The present invention is directed toward respirable dry pow... |
|
|
Invention
|
Antifungal formulations for pulmonary administration comprising itraconazole.
The invention rela... |
|
|
Invention
|
Antifungal formulations for pulmonary administration comprising itraconazole. The invention relat... |
|
|
Invention
|
Methods of treating fungal infections. The invention relates to methods of treating fungal infect... |
|
2018
|
Invention
|
Itraconazole dry powders.
In one aspect, a dry powder comprising respirable dry particles that c... |
|
2017
|
Invention
|
Antifungal dry powders. The invention relates to dry powder formulations comprising respirable dr... |
|
|
Invention
|
Dry powder formulations and methods for treating pulmonary diseases.
The present invention is di... |
|
|
Invention
|
Tiotropium dry powders.
The present invention relates to respirable dry powder comprising respir... |
|
|
Invention
|
Methods for producing respirable dry powders. The invention related to dry powders that contain a... |
|
|
P/S
|
Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmace... |
|
2016
|
Invention
|
Cationic dry powders. The invention relates to respirable dry particles that contain one or more ... |
|
2015
|
Invention
|
Improved stability of dry powders containing tiotropium and amino acid.
The invention relates to... |
|
|
Invention
|
Formulations containing tiotropium, amino acid and acid and methods thereof.
A dry powder contai... |
|
|
Invention
|
Formulations containing tiotropium, amino acid and acid and methods thereof. A dry powder contain... |
|
|
Invention
|
Improved stability of dry powders containing tiotropium and amino acid. The invention relates to,... |
|
|
Invention
|
Tiotropium dry powders. The present invention relates to respirable dry powder comprising respira... |
|
|
Invention
|
Dry powder formulations and methods for treating pulmonary diseases. The present invention is dir... |
|
2014
|
Invention
|
Respirably dry powder comprising calcium lactate, sodium chloride and leucine. The present invent... |
|
2011
|
Invention
|
Monovalent metal cation dry powders for inhalation. The present invention is directed toward resp... |
|
|
Invention
|
Monovalent metal cation dry powders for inhalation. ABSTRACT The present invention is directed to... |
|
2009
|
P/S
|
Medical research devices for measuring, sampling, and characterizing exhaled aerosol particles an... |
|
2007
|
Invention
|
Method and device for decreasing contamination. Methods and devices to determine rate of particle... |
